Biomarkers for alzheimer’s disease drug development

Biomarkers for alzheimer’s disease drug development

Author
Robert Perneczky
Publication Year
2024
Publisher
Springer
Language
English
Document Type
Book
Faculty / Subject Heading
Medical Science

Helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer’s disease field are performed.


Keywords: Digital biomarkers / Neuroimaging analysis / Neurodegenerative disorder / Drug targets / Amyloid -targeting antibody / Preclinical and clinical research / Biomedicine - General / Neurosciences / Pharmacology / Toxicology / Biomedicine